Acadia Healthcare (NASDAQ:ACHC) Stock Falls 5.1% - Here's Why

Key Points

• Acadia Healthcare shares fell 5.1% to roughly $29.75, with trading volume about 73% below the stock’s average session volume.
• Analyst sentiment remains mixed: eight analysts rate the stock a Buy, five a Hold and two a Sell, resulting in an overall “Hold” rating and a consensus price target of $30.69.
• The company exceeded quarterly earnings and revenue expectations, reporting $0.38 EPS and $865.84 million in revenue, but revenue declined 0.4% year over year and Acadia posted a negative net margin of 33.44%.

Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report) shares were down 5.1% on Tuesday. The stock traded as low as $29.78 and last traded at $29.7540. Approximately 762,978 shares were traded during mid-day trading, a decline of 73% from the average session volume of 2,825,651 shares. The stock had previously closed at $31.34.

Analyst Ratings Changes

Several equities analysts have issued reports on the stock. Barclays lifted their price target on shares of Acadia Healthcare from $25.00 to $32.00 and gave the stock an "equal weight" rating in a report on Thursday, July 30th. Weiss Ratings reiterated a "sell (d)" rating on shares of Acadia Healthcare in a report on Wednesday, September 9th. Leerink Partners raised their price objective on Acadia Healthcare from $30.00 to $33.00 and gave the stock a "market perform" rating in a research report on Wednesday, September 23rd. Raymond James Financial downgraded Acadia Healthcare from a "strong-buy" rating to an "outperform" rating and set a $39.00 target price on the stock. in a research note on Monday, September 28th. Finally, TD Cowen boosted their target price on Acadia Healthcare from $30.00 to $36.00 and gave the stock a "buy" rating in a research note on Tuesday, July 14th. Eight research analysts have rated the stock with a Buy rating, five have given a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $30.69.

Acadia Healthcare Price Performance

The company has a debt-to-equity ratio of 1.20, a current ratio of 1.57 and a quick ratio of 1.57. The stock has a market cap of $2.74 billion, a price-to-earnings ratio of -2.37, a P/E/G ratio of 10.15 and a beta of 0.63. The stock has a fifty day moving average of $28.94 and a 200 day moving average of $25.31.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its quarterly earnings results on Tuesday, July 28th. The company reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.35 by $0.03. Acadia Healthcare had a negative net margin of 33.44% and a positive return on equity of 6.19%. The company had revenue of $865.84 million for the quarter, compared to the consensus estimate of $844.19 million. During the same quarter in the prior year, the company earned $0.83 EPS. Acadia Healthcare's quarterly revenue was down .4% on a year-over-year basis. On average, analysts expect that Acadia Healthcare Company, Inc. will post 1.55 EPS for the current fiscal year.

Institutional Trading of Acadia Healthcare

Large investors have recently made changes to their positions in the business. Allworth Financial LP acquired a new position in shares of Acadia Healthcare during the 2nd quarter worth $45,000. Global Retirement Partners LLC acquired a new position in shares of Acadia Healthcare during the 2nd quarter worth approximately $68,000. Integrated Wealth Concepts LLC purchased a new stake in shares of Acadia Healthcare in the second quarter valued at $79,000. Quantbot Technologies LP purchased a new position in Acadia Healthcare in the 2nd quarter valued at about $88,000. Finally, WINTON GROUP Ltd boosted its position in Acadia Healthcare by 1.4% during the second quarter. WINTON GROUP Ltd now owns 255,451 shares of the company's stock worth $7,543,000 after acquiring an additional 3,449 shares during the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services headquartered in Franklin, Tennessee. The company operates psychiatric hospitals, specialty treatment facilities and outpatient programs focused on mental health and substance use disorders.

Acadia's services include inpatient and outpatient psychiatric care, addiction treatment, residential treatment, eating-disorder programs, and services for children and adolescents. Its facilities serve patients with a range of behavioral health conditions, including depression, anxiety, trauma-related disorders and substance use disorders.

Founded in 2005, Acadia operates primarily in the United States and also has a significant presence in the United Kingdom through its ownership of Priory, a behavioral healthcare provider.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.